A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.
about
High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activityHMGA1-pseudogenes and cancerBinding the mammalian high mobility group protein AT-hook 2 to AT-rich deoxyoligonucleotides: enthalpy-entropy compensation.Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancerTranscription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network.Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation.HMG-I/Y, a new c-Myc target gene and potential oncogeneArchitectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.Hsa-miRNA-765 as a key mediator for inhibiting growth, migration and invasion in fulvestrant-treated prostate cancer.HMGA proteins: flexibility finds a nuclear niche?Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?Causes and consequences of DNA hypomethylation in human cancer.Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation statusHMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancerRegulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasionHigh mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells.Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.HMG-I/Y in human breast cancer cell lines.Candidate agents for papillary thyroid cancer identified by gene expression analysis.High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells.Expression of HMGI(Y) associated with malignant phenotype of human gastric tissue.Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.Human HMGA2 promoter is coregulated by a polymorphic dinucleotide (TC)-repeat.Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker.Expression of the HMGI(Y) gene in human colorectal cancer.Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer.Increased expression of high mobility group A proteins in lung cancer.Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma
P2860
Q24300124-19FE8ABE-ECF4-4FF1-8DDA-B99A3B476277Q28072498-21001C8D-FC45-431F-82AE-55318515CD9EQ30481431-86AC2923-F4A8-4C0D-8C03-C86607FD0A04Q31119968-9D7525C4-2BDE-4A7C-A58B-0546D7DBEE95Q33337226-C06C4C21-453C-4F49-9C69-FCA3A8B94614Q33921793-8CBE5060-B442-490F-A266-8A029EC92965Q33964722-FE941F52-C46B-4C6A-9619-5BF5B0CA2A7AQ33966952-EED7AB44-EE30-4729-B4A2-EA66FABCF0D3Q34721443-7D652F7F-1FD8-4841-8803-644673B9CD2BQ35170430-42D3575E-8067-4897-8B13-B2169EAF2DEAQ35191557-E518D58E-83BC-4981-97EC-D07DA4138DDCQ35788098-687A39A5-3FD0-49EF-9170-3EA8E32632DCQ35925285-50605FEA-9544-470A-98B1-2C2F2D0A69F8Q36164751-8D335E3B-76A7-4F91-AD8E-3D2123B2D32CQ36621487-819F0CB4-3FD7-4407-BD87-3354244CC42DQ37119968-21C441FF-3B37-4094-A615-C6C56EA466ACQ37340421-ECB4F650-2C3E-4DE5-8595-475A9400058DQ38751649-63FB8BDB-FEDE-458E-A399-0AE7E900E7F7Q39418448-84C4FB18-B870-48E6-8044-5DFAE6D13218Q40162429-4609A956-B941-42B7-B24B-96054503549EQ40733016-17CDF89E-FA5D-4B8C-A36B-6E4932BE1BA6Q43548418-60605D56-985F-42D8-ADF8-1403C462A1AAQ47431419-6DE59F8A-4763-48E5-A5C8-D4AAF7D2D1A3Q47953782-C3CD19D6-0095-4866-AA08-533CDFE3BF9AQ50797819-B4603EA7-46CB-4BEF-B6EB-680D38D5E61AQ52109467-7F68CBCB-5FDE-4076-A999-4D9D243B2784Q53354023-56A9F5D7-9DC6-4DB5-8FA3-794479D11EC5Q53421506-C900AD4C-4060-4A69-87B2-425E22BD3A4FQ53583365-682069D1-EC41-4CCA-8772-04DFA4D2E2C0Q53633597-0F63E761-CCCD-405C-AE6A-35231A3250B8Q54473091-7E85197F-BCF2-4E6B-930C-93DA80414DB3Q58291372-E622E6DC-7DAE-46FE-A455-34C77F3E17FB
P2860
A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A retrospective study of high ...... ined by in situ hybridization.
@ast
A retrospective study of high ...... ined by in situ hybridization.
@en
type
label
A retrospective study of high ...... ined by in situ hybridization.
@ast
A retrospective study of high ...... ined by in situ hybridization.
@en
prefLabel
A retrospective study of high ...... ined by in situ hybridization.
@ast
A retrospective study of high ...... ined by in situ hybridization.
@en
P2093
P2860
P356
P1476
A retrospective study of high ...... ined by in situ hybridization.
@en
P2093
Debruyne FM
Karthaus HF
Schalken JA
van der Poel HG
P2860
P2888
P304
P356
10.1038/BJC.1996.403
P407
P577
1996-08-01T00:00:00Z
P5875
P6179
1030814323